Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Karyopharm Therapeutics Received FDA Approval for Labeling for XPOVIO

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208088

March 29, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208088

Credit Suisse Maintains Outperform on Radius Global Infr, Lowers Price Target to $23

Today, 6:35 AM

Credit Suisse analyst Sami Badri maintains Radius Global Infr (NASDAQ:RADI) with a Outperform and lowers the price target from $24 to $23.

Today, 6:35 AM

-Reuters

Today, 6:35 AM

Morgan Stanley analyst Dara Mohsenian maintains Procter & Gamble (NYSE:PG) with a Overweight and raises the price target from $155 to $160.